Webinars

Upcoming Webinars

April 2, 2026

Extended Nucleic Acid Therapeutics: Unlocking potential through tiny methylene chemical modifications
SPEAKER/S: Ken Yamada, PhD

TIME: 11-12pm EDT / 5-6pm CEST
April 16, 2026

Trainee Spotlight Series: 2025 Oligo Meeting Poster Winners 5
SPEAKER/S: Nadine Maas / Irene Flavia Ferro / Deeksha Satyabola

TIME: 11-12pm EDT / 5-6pm CEST
May 7, 2026

Selection of DNA Aptamers to Inhibit TDP-43 Aggregation in ALS
SPEAKER/S: Daniel Knight

TIME: 11-12pm EDT / 5-6pm CEST
May 21, 2026

Bioanalysis of Oligonucleotide Therapeutics via Nucleic Acid Nanorobotic Platform
SPEAKER/S: Tarin Taleb

TIME: 11-12pm EDT / 5-6pm CEST
June 4, 2026

Chance, Choice, and Conviction: A Career in Oligonucleotide Therapeutics
SPEAKER/S: Jim Weterings, PhD

TIME: 11-12pm EDT / 5-6pm CEST
June 18, 2026

Advancing Precision Medicine: Oligonucleotide Therapeutics and Genome Editing
SPEAKER/S: Laura Sepp-Lorenzino, Ph.D.

TIME: 11-12pm EDT / 5-6pm CEST
September 24, 2026

Immunogenicity Risk Assessment for Nucleic Acid Therapeutics
SPEAKER/S: Joanna Grudzinska-Goebel / Pedro Morais, PhD

TIME: 11-12pm EDT / 5-6pm CEST

Previous 1

Recent Webinars

Past Webinars

Non-viral DNA delivery: Opportunities and challenges

Non-viral DNA delivery: Opportunities and challenges

ASO activity and distribution after LNP delivery

ASO activity and distribution after LNP delivery

Muscle targeted siRNA Conjugates for Pompe Disease

Muscle targeted siRNA Conjugates for Pompe Disease

Developing Oligonucleotides Into Therapies: Opportunities and Challenges

Developing Oligonucleotides Into Therapies: Opportunities and Challenges

Pathways for patient-centered interventional genomic medicine

Pathways for patient-centered interventional genomic medicine

Introduction to Nucleic Acid Immunity, and It’s Implications For Optimizing Cancer Immunotherapy

Introduction to Nucleic Acid Immunity, and It’s Implications For Optimizing Cancer Immunotherapy

Non-viral DNA delivery: Opportunities and challenges

Non-viral DNA delivery: Opportunities and challenges

OTS2024-03-13T06:57:28+00:00June 27th, 2023|Categories: Past Webinars|

Time: 8AM PST | 11AM EST | 5PM CET Date: October 12, 2023 This presentation will cover defining the ...

ASO activity and distribution after LNP delivery

ASO activity and distribution after LNP delivery

OTS2024-03-13T06:57:19+00:00June 27th, 2023|Categories: Past Webinars|

Time: 8AM PST | 11AM EST | 5PM CET Date: Thursday, September 14, 2023 Webinar title: Assessing antisense ...

Muscle targeted siRNA Conjugates for Pompe Disease

Muscle targeted siRNA Conjugates for Pompe Disease

OTS2023-11-01T06:24:49+00:00June 27th, 2023|Categories: Past Webinars|

Time: 8AM PST / 11AM EST / 5PM CET Date: August 3, 2023 Aro Biotx is focused on ...

Developing Oligonucleotides Into Therapies: Opportunities and Challenges

Developing Oligonucleotides Into Therapies: Opportunities and Challenges

OTS2023-11-01T06:24:38+00:00June 27th, 2023|Categories: Past Webinars|

Time: 8AM PST / 11AM EST / 5PM CET Date: July 6, 2023 ...

Pathways for patient-centered interventional genomic medicine

Pathways for patient-centered interventional genomic medicine

OTS2023-11-01T06:24:29+00:00April 26th, 2023|Categories: Past Webinars|

Time: 8AM PST | 11AM EST | 5PM CET Date: June 22, 2023 Speakers: ...

Introduction to Nucleic Acid Immunity, and It’s Implications For Optimizing Cancer Immunotherapy

Introduction to Nucleic Acid Immunity, and It’s Implications For Optimizing Cancer Immunotherapy

OTS2023-11-01T06:24:21+00:00April 26th, 2023|Categories: Past Webinars|

Time: 8AM PST | 11AM EST | 5PM CET Date: June 8, 2023 Starting from the concept and ...

Previous 1 2 3 4 5 678 9 10 11 12 13 14 15 Next

Upcoming Webinars

Extended Nucleic Acid Therapeutics: Unlocking potential through tiny methylene chemical modifications

Trainee Spotlight Series: 2025 Oligo Meeting Poster Winners 5

Selection of DNA Aptamers to Inhibit TDP-43 Aggregation in ALS

Bioanalysis of Oligonucleotide Therapeutics via Nucleic Acid Nanorobotic Platform

Chance, Choice, and Conviction: A Career in Oligonucleotide Therapeutics

Advancing Precision Medicine: Oligonucleotide Therapeutics and Genome Editing

Immunogenicity Risk Assessment for Nucleic Acid Therapeutics

Recent Webinars

Past Webinars

Non-viral DNA delivery: Opportunities and challenges

ASO activity and distribution after LNP delivery

Muscle targeted siRNA Conjugates for Pompe Disease

Developing Oligonucleotides Into Therapies: Opportunities and Challenges

Pathways for patient-centered interventional genomic medicine

Introduction to Nucleic Acid Immunity, and It’s Implications For Optimizing Cancer Immunotherapy

Subscribe to our Newsletter

Resources

Stay Connected

Search

Webinars

Upcoming Webinars

Recent Webinars

Past Webinars

Subscribe to our Newsletter

Resources

Stay Connected

Search

Login to your account

Reset Password

Signup to your Account

Answers

Job Alerts

Account Activation